“…Since the discovery of acarbose, first -glucosidase inhibitor lots of synthetic Tanabe et al, 2007;Liu et al, 2007) and natural molecules (Luo et al, 2007;Saludes et al, 2007;Du et al, 2006) reported for the management of type 2 diabetes, but continuous administration of these agents causing adverse effects like diarrhea, abdominal discomfort, flatulence (Campbell et al, 2000), and hepatotoxicity (Hsiao et al, 2006). So, the research continues to find other problem solving alternatives.…”